triamcinolone has been researched along with Central Retinal Edema, Cystoid in 116 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (0.86) | 18.7374 |
1990's | 3 (2.59) | 18.2507 |
2000's | 44 (37.93) | 29.6817 |
2010's | 58 (50.00) | 24.3611 |
2020's | 10 (8.62) | 2.80 |
Authors | Studies |
---|---|
Bonifazzi, C; Parmeggiani, F; Sorrentino, FS | 1 |
Arias, L; Caminal, J; Cobos, E; Garcia-Bru, P; Lorenzo, D; Morwani, R; Obis, J; Padron-Perez, N | 1 |
Chang, DJ; Chung, YR; Jee, D; Jin, KW; Kim, S; Kim, TM; Kwon, JW; Lee, DY; Lee, K; Mun, Y; Park, C; Park, KH; Park, RW; Park, SJ; Roh, YJ; Song, JH; Woo, SJ; Yoo, S | 1 |
Erdogan, G; Gumus, G; Gunay, BO; Karatas Durusoy, G | 1 |
Anderson, HE; Chiang, A; Garg, SJ; Hsu, J; Liu, CK; Mahmoudzadeh, R; Nguyen, MK; Salabati, M; Spirn, MJ; Wakabayashi, T | 1 |
Basic-Jukic, N; Juric Tomasevic, B; Juric, I | 1 |
Li, T; Mir, TA; Rittiphairoj, T; Virgili, G | 1 |
Kankaanpää, E; Pesonen, M; Vottonen, P | 1 |
An, JH; Kim, YC | 1 |
Barnes, R; Barry, R; Barthelmes, D; Bhandari, S; Gillies, M; Nguyen, V; Squirrell, D; Tan, T; Wang, N; Wells, JM | 1 |
Evans, JR; Gordon, I; Lucenteforte, E; Parravano, M; Virgili, G | 2 |
Eldem, B; Kadayıfçılar, S; Koç, İ | 1 |
Karst, S; Mitsch, C; Schmidt-Erfurth, U; Scholda, C | 1 |
Garweg, JG | 1 |
Campain, A; Fraser-Bell, S; Gillies, MC; Hennings, C; Mehta, H; Nguyen, V | 1 |
Abegão Pinto, L; Leal, I; Sousa, DC | 1 |
Fukushima, A; Goto, R; Hikichi, Y; Kitano, S; Sakamoto, T; Vataire, AL | 1 |
Li, M; Qian, T; Wan, Y; Xu, X; Zhao, M | 1 |
Almeida, DR; Belliveau, MJ; Dorrepaal, SJ; Gale, JS; Minuk, A | 1 |
Kester, E; Shaikh, S; Zarifa, R | 1 |
Corduneanu, A; Gherasim, V; Sevciuc, R | 1 |
Beardsley, RM; Flaxel, CJ; Messenger, WB | 1 |
Kiss, CG; Kroh, M; Montuoro, A; Munk, MR; Roberts, P; Schmidt-Erfurth, U; Simader, C; Steiner, I; Sulzbacher, F | 1 |
Enns, EA; Goldhaber-Fiebert, JD; Matesic, B; Owens, DK; Pershing, S | 1 |
Chen, C; Cugati, S; Lee, A; Thoo, S | 1 |
Avram, C; Camburu, R; Ochinciuc, U; Sarbu, L; Stamate, A; Zemba, M | 1 |
Evans, JR; Menchini, F; Parravano, M; Virgili, G | 1 |
Sobaci, G; Yolcu, Ü | 1 |
Adelman, RA; Bopp, S; Ducournau, D; Parnes, AJ; Saad Othman, I | 1 |
Chia, SN; Lam, FC; Lee, RM | 1 |
Ah-Kee, EY; Chew, N; Chia, SN; Gupta, M; Lim, LT | 1 |
Gewaily, D; Greenberg, PB; Muthuswamy, K | 1 |
Cáceres-del-Carpio, J; Costa, RD; Haider, A; Kuppermann, BD; Narayanan, R | 1 |
Baillif, S; Gastaud, P; Landré, C; Zourdani, A | 1 |
Ercalik, NY; Imamoglu, S; Kumral, ET; Vural, ET; Yenerel, NM | 1 |
Gao, Y; Lan, J; Wang, W; Xie, L; Zhang, L | 1 |
Boden, KT; Seuthe, AM; Szurman, P | 1 |
Gerding, H; Loukopoulos, V; Meier, C; Riese, J; Timmermann, M | 1 |
Boldt, HC; Kwon, YH; Oetting, TA; Rauen, M | 1 |
Meyer, L; Michel, G; Naoun, KO | 1 |
Azen, SP; Chung, EJ; Freeman, WR; Koh, HJ; Lee, H | 1 |
Ardjomand, N; El-Shabrawi, Y; Maier, R; Steinbrugger, I; Wedrich, A; Weger, M; Wegscheider, BJ; Weiss, K | 1 |
Montero, JA; Ruiz-Moreno, JM | 1 |
Bhurayanontachai, P; Ma-a-lee, A; Ratanasukon, M | 1 |
Menchini, F; Parravano, M; Virgili, G | 1 |
Bouhaimed, M; Moussa, M; Othman, IS | 1 |
Gillies, M; Kuo, CH; McCluskey, P | 1 |
Kim, YK; Lee, YJ; Park, KH; Woo, SJ | 1 |
Almasalamy, SM; Rahman Mahdy, RA; Saleh, MM | 1 |
Al Saeidi, R; Haritoglou, C; Kook, D; Kreutzer, TC; Neubauer, AS; Ulbig, MW; Wolf, A | 1 |
Gatzioufas, Z; Hille, K; Khurieva-Sattler, E; Krause, M; Löw, U; Ruprecht, K; Seitz, B; Toropygin, S | 1 |
Cennamo, G; Cennamo, GL; D'Amico, G; de Crecchio, G; Farese, E; Finelli, M; Forte, R; Nicoletti, G | 1 |
Gerding, H; Hefner, L; Loukopoulos, V; Meier, C; Riese, J; Timmermann, M | 1 |
Joussen, AM; Kakkassery, V; Winterhalter, S | 1 |
Cordero-Coma, M; Gallagher, MJ; Lavaque, AJ; Padula, WV; Yilmaz, T | 1 |
Giuliari, G | 1 |
Synek, S; Vojniković, B | 1 |
Arruabarrena, C; Contreras, I; Figueroa, MS; García-Pérez, JL; Gil-Cazorla, R; Noval, S; Sales, M | 1 |
Kim, HH; Kim, KS; Lee, MY | 1 |
Dib, E; Farah, ME; Furlani, BA; Melo, GB; Penha, FM; Rodrigues, EB | 1 |
Eneh, A; Gale, J; Schweitzer, KD | 1 |
Koch, F; Koss, MJ; Naser, H; Singh, P | 1 |
Synek, S; Veselý, P | 1 |
Bakiah, S; Norlaili, M; Zunaina, E | 1 |
Díaz-Llopis, M; Dolz-Marco, R; Gallego-Pinazo, R; Lleó-Pérez, A; Martínez Castillo, S | 1 |
Chan, CK; Lai, TY; Lam, DS; Lee, VY; Li, CL; Liu, DT; Mohamed, S | 1 |
Fekrat, S; Hahn, P | 1 |
Stewart, MW | 1 |
Ignat, F; Irimia, A | 1 |
Gundogan, FC; Sobaci, G; Tas, A | 1 |
Rehak, M; Scholz, M; Spies, E; Wiedemann, P | 1 |
Brunetti, M; Menchini, F; Parravano, M; Virgili, G | 1 |
Bang, YW; Kim, YW; Kwon, SI; Lee, JY; Park, IW | 1 |
Cetin, EN; Yıldırım, C | 1 |
Baek, SU; Kwon, SI; Park, IW | 1 |
Martidis, A; Nelson, ML | 1 |
Haritoglou, C; Kampik, A | 2 |
Chen, SD; Lochhead, J; McDonald, B; Patel, CK | 1 |
Chan, CK; Chan, WM; Fan, DS; Lai, WW; Lam, DS; Lee, VY | 1 |
Ip, MS | 1 |
Gupta, R; Negi, A; Vernon, SA | 1 |
Kumar, A; Tewari, HK; Venkatesh, P; Verma, LK; Vivek, MB | 1 |
Ip, MS; Scott, IU | 1 |
Erkiliç, K; Evereklioglu, C; Oner, A; Ozkiris, A | 1 |
Belzunce-Manterola, A; García-Layana, A; Sádaba-Echarri, LM; Salinas-Alamán, A | 1 |
Prasad, S; Srinivasan, S | 1 |
Pathmanathan, T; Reck, AC | 1 |
Ferrer-Novella, E; Honrubia-López, FM; Ruiz-Moreno, O; Sánchez-Cano, A; Torrón-Fernández-Blanco, C | 1 |
Bencić, G; Mandić, Z; Vatavuk, Z | 1 |
Behar-Cohen, F; Iossifov, D; Metge, F; Miyamoto, N | 1 |
Canning, CR; Ung, T; Williams, CP | 1 |
Ahmadieh, H; Ramezani, A; Tabatabaei, H | 1 |
Child, AH; Comeglio, P; Masood, I; Negi, A; Vernon, SA | 1 |
Casswell, AG; Dubois, VD; Mokete, B; Rajak, SN | 1 |
Feucht, M; Pressmar, S; Richard, G; Sturm, V; Weissmann, J | 1 |
Gillies, MC; Islam, FM; Larsson, J; Wong, TY; Zhu, M | 1 |
Charles, S; Gupta, A | 1 |
Cleary, PE; Gibran, SK; Jungkim, S; Khan, K | 1 |
He, YG; Kramar, M; Vu, L; Whitson, JT | 1 |
Bakri, SJ; Ekdawi, NS | 1 |
Bearelly, S; Cooney, MJ; Fekrat, S; Stinnett, S | 1 |
Park, KH; Sohn, JH; Song, SJ | 1 |
Alfaro, DV; Fernández, M; Gómez-Ulla, F; Marticorena, J; Méndez, ER; Rothen, M | 1 |
Kumar, A; Sinha, S | 1 |
Chong, CC; Grover, D; Li, TJ | 1 |
Oueghlani, E; Pavésio, CE | 1 |
Chacón-Lara, A; Hernández-Da Mota, SE; Hernández-Vázquez, E | 1 |
Ichiishi, A; Kosaka, S; Kotake, S; Matsuda, H; Sasamoto, Y; Yoshikawa, K | 1 |
Frambach, DA; Ortega-Larrocea, G; Rao, NA; Rutzen, AR | 1 |
Gonder, JR; Sheidow, TG | 1 |
Hall, AJ | 1 |
Branley, M; Larkin, G; Lightman, S; Young, S | 1 |
Kaiser, PK; Lowder, CY; Moshfeghi, DM; Roth, DB | 1 |
Cunha-Vaz, JG; Jennings, T; Rusin, MM; Tessler, HH | 1 |
29 review(s) available for triamcinolone and Central Retinal Edema, Cystoid
Article | Year |
---|---|
Intravitreal steroids for macular edema in diabetes.
Topics: Anti-Inflammatory Agents; Bevacizumab; Bias; Confidence Intervals; Dexamethasone; Diabetic Retinopathy; Drug Implants; Fluocinolone Acetonide; Glucocorticoids; Humans; Intravitreal Injections; Macular Edema; Randomized Controlled Trials as Topic; Ranibizumab; Steroids; Triamcinolone; Vascular Endothelial Growth Factor A; Visual Acuity; Vitreous Body | 2020 |
Anti-vascular endothelial growth factor for diabetic macular oedema: a network meta-analysis.
Topics: Angiogenesis Inhibitors; Aptamers, Nucleotide; Bevacizumab; Diabetic Retinopathy; Humans; Laser Coagulation; Macular Edema; Network Meta-Analysis; Quality of Life; Randomized Controlled Trials as Topic; Ranibizumab; Receptors, Vascular Endothelial Growth Factor; Recombinant Fusion Proteins; Triamcinolone; Vascular Endothelial Growth Factor A; Visual Acuity | 2017 |
Macular Edema in Childhood Uveitis.
Topics: Adrenal Cortex Hormones; Arthritis, Juvenile; Child; Early Diagnosis; Early Medical Intervention; Humans; Interdisciplinary Communication; Intersectoral Collaboration; Intravitreal Injections; Macular Edema; Methotrexate; Treatment Outcome; Triamcinolone; Tumor Necrosis Factor-alpha; Uveitis; Vision Disorders | 2018 |
Anti-vascular endothelial growth factor combined with intravitreal steroids for diabetic macular oedema.
Topics: Bevacizumab; Dexamethasone; Diabetic Retinopathy; Drug Therapy, Combination; Glucocorticoids; Humans; Intraocular Pressure; Intravitreal Injections; Macula Lutea; Macular Edema; Randomized Controlled Trials as Topic; Ranibizumab; Receptors, Vascular Endothelial Growth Factor; Triamcinolone; Vascular Endothelial Growth Factor A; Visual Acuity | 2018 |
Anti-vascular endothelial growth factor for diabetic macular oedema: a network meta-analysis.
Topics: Angiogenesis Inhibitors; Aptamers, Nucleotide; Bevacizumab; Diabetic Retinopathy; Humans; Laser Coagulation; Macular Edema; Network Meta-Analysis; Quality of Life; Randomized Controlled Trials as Topic; Ranibizumab; Receptors, Vascular Endothelial Growth Factor; Recombinant Fusion Proteins; Triamcinolone; Vascular Endothelial Growth Factor A; Visual Acuity | 2018 |
Comparison of the efficacy and safety of drug therapies for macular edema secondary to central retinal vein occlusion.
Topics: Adrenal Cortex Hormones; Aptamers, Nucleotide; Dexamethasone; Humans; Intraocular Pressure; Intravitreal Injections; Macular Edema; Network Meta-Analysis; Randomized Controlled Trials as Topic; Ranibizumab; Receptors, Vascular Endothelial Growth Factor; Recombinant Fusion Proteins; Retinal Vein Occlusion; Risk Assessment; Treatment Outcome; Triamcinolone; Vascular Endothelial Growth Factor A | 2018 |
Fluocinolone acetonide intravitreal implant for the treatment of diabetic macular edema.
Topics: Dexamethasone; Diabetic Retinopathy; Drug Implants; Fluocinolone Acetonide; Humans; Intraocular Pressure; Light Coagulation; Macular Edema; Quality of Life; Triamcinolone; Vascular Endothelial Growth Factor A; Vitrectomy | 2013 |
Anti-vascular endothelial growth factor for diabetic macular oedema.
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Aptamers, Nucleotide; Bevacizumab; Diabetic Retinopathy; Humans; Laser Coagulation; Macular Edema; Randomized Controlled Trials as Topic; Ranibizumab; Receptors, Vascular Endothelial Growth Factor; Recombinant Fusion Proteins; Triamcinolone; Vascular Endothelial Growth Factor A | 2014 |
Macular grid laser photocoagulation for branch retinal vein occlusion.
Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Bevacizumab; Humans; Laser Coagulation; Macular Edema; Randomized Controlled Trials as Topic; Retinal Vein Occlusion; Triamcinolone; Visual Acuity | 2015 |
Advances in the management of diabetic macular oedema based on evidence from the Diabetic Retinopathy Clinical Research Network.
Topics: Adrenal Cortex Hormones; Bevacizumab; Biomedical Research; Diabetic Retinopathy; Disease Management; Disease Progression; Humans; Light Coagulation; Macular Edema; Ranibizumab; Retina; Tomography, Optical Coherence; Triamcinolone; Vascular Endothelial Growth Factor A; Visual Acuity; Vitrectomy | 2015 |
Intravitreal steroids versus observation for macular edema secondary to central retinal vein occlusion.
Topics: Dexamethasone; Humans; Intravitreal Injections; Macular Edema; Randomized Controlled Trials as Topic; Retinal Vein Occlusion; Steroids; Triamcinolone; Visual Acuity; Watchful Waiting | 2015 |
Corticosteroids: Triamcinolone, Dexamethasone and Fluocinolone.
Topics: Dexamethasone; Drug Delivery Systems; Fluocinolone Acetonide; Glucocorticoids; Humans; Macular Edema; Triamcinolone | 2016 |
The Efficacy and Safety of Current Treatments in Diabetic Macular Edema: A Systematic Review and Network Meta-Analysis.
Topics: Diabetic Retinopathy; Humans; Intravitreal Injections; Laser Therapy; Macular Edema; Network Meta-Analysis; Patient Safety; Randomized Controlled Trials as Topic; Ranibizumab; Receptors, Vascular Endothelial Growth Factor; Recombinant Fusion Proteins; Treatment Outcome; Triamcinolone; Visual Acuity | 2016 |
Intravitreal inserts of steroids to treat diabetic macular edema.
Topics: Dexamethasone; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Dose-Response Relationship, Drug; Fluocinolone Acetonide; Glucocorticoids; Humans; Macular Edema; Triamcinolone; Vitreous Body | 2009 |
Antiangiogenic therapy with anti-vascular endothelial growth factor modalities for diabetic macular oedema.
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Aptamers, Nucleotide; Bevacizumab; Diabetic Retinopathy; Humans; Macular Edema; Randomized Controlled Trials as Topic; Triamcinolone; Vascular Endothelial Growth Factor A | 2009 |
[Anti-VEGF inhibitors and their role in the treatment of diabetic macular oedema].
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Aptamers, Nucleotide; Bevacizumab; Blood-Retinal Barrier; Capillary Permeability; Clinical Trials as Topic; Combined Modality Therapy; Diabetic Retinopathy; Fluorescein Angiography; Humans; Intravitreal Injections; Laser Coagulation; Macular Edema; Middle Aged; Off-Label Use; Ranibizumab; Receptors, Vascular Endothelial Growth Factor; Recombinant Fusion Proteins; Retinoscopy; Triamcinolone; Vascular Endothelial Growth Factor A | 2010 |
Triamcinolone and intraocular sustained-release delivery systems in diabetic retinopathy.
Topics: Anti-Inflammatory Agents; Blood-Retinal Barrier; Delayed-Action Preparations; Diabetic Retinopathy; Drug Delivery Systems; Eye; Humans; Injections, Intraocular; Intravitreal Injections; Macular Edema; Randomized Controlled Trials as Topic; Triamcinolone; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Vitreous Body | 2011 |
Toxicological considerations for intravitreal drugs.
Topics: Animals; Anti-Bacterial Agents; Antibodies, Monoclonal, Humanized; Bevacizumab; Clinical Trials as Topic; Humans; Intravitreal Injections; Macular Degeneration; Macular Edema; Ranibizumab; Triamcinolone; Vascular Endothelial Growth Factor A | 2011 |
Best practices for treatment of retinal vein occlusion.
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Dexamethasone; Glucocorticoids; Humans; Macular Edema; Ranibizumab; Retinal Vein Occlusion; Triamcinolone; Vascular Endothelial Growth Factor A | 2012 |
Corticosteroid use for diabetic macular edema: old fad or new trend?
Topics: Anti-Inflammatory Agents; Dexamethasone; Diabetic Retinopathy; Drug Administration Schedule; Drug Implants; Female; Fluocinolone Acetonide; Humans; Intravitreal Injections; Macular Edema; Male; Triamcinolone; Visual Acuity | 2012 |
[Treatment in diabetic maculopathy].
Topics: Angiogenesis Inhibitors; Diabetic Retinopathy; Drug Therapy, Combination; Fluorescein Angiography; Glucocorticoids; Humans; Intravitreal Injections; Lasers, Gas; Light Coagulation; Macular Edema; Randomized Controlled Trials as Topic; Risk Factors; Treatment Outcome; Triamcinolone; Vitrectomy | 2011 |
Antiangiogenic therapy with anti-vascular endothelial growth factor modalities for diabetic macular oedema.
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Aptamers, Nucleotide; Bevacizumab; Diabetic Retinopathy; Humans; Laser Coagulation; Macular Edema; Randomized Controlled Trials as Topic; Ranibizumab; Triamcinolone; Vascular Endothelial Growth Factor A | 2012 |
Adjuvant treatment modalities to control macular edema in diabetic patients undergoing cataract surgery.
Topics: Angiogenesis Inhibitors; Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Bevacizumab; Cataract; Chemotherapy, Adjuvant; Diabetic Retinopathy; Disease Progression; Humans; Intravitreal Injections; Macular Edema; Phacoemulsification; Ranibizumab; Triamcinolone | 2013 |
Managing cystoid macular edema after cataract surgery.
Topics: Cataract Extraction; Humans; Macular Edema; Postoperative Complications; Risk Factors; Triamcinolone; Vitrectomy | 2003 |
[Surgery for macular edema].
Topics: Anti-Inflammatory Agents; Humans; Laser Therapy; Macular Edema; Patient Care Management; Practice Patterns, Physicians'; Triamcinolone; Vitrectomy | 2004 |
Pseudohypopyon after intravitreal triamcinolone injection for the treatment of pseudophakic cystoid macular oedema.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Aqueous Humor; Endophthalmitis; Female; Humans; Injections; Macular Edema; Pseudophakia; Triamcinolone | 2004 |
Intravitreal injection of triamcinolone: an emerging treatment for diabetic macular edema.
Topics: Anti-Inflammatory Agents; Diabetic Retinopathy; Humans; Macular Edema; Triamcinolone | 2004 |
Intravitreal triamcinolone for the treatment of diabetic macular edema.
Topics: Anti-Inflammatory Agents; Diabetic Retinopathy; Half-Life; Humans; Laser Coagulation; Macular Edema; Triamcinolone; Vitreous Body | 2006 |
Intravitreal steroids for macular edema in diabetes.
Topics: Anti-Inflammatory Agents; Dexamethasone; Diabetic Retinopathy; Drug Implants; Fluocinolone Acetonide; Glucocorticoids; Humans; Injections; Macular Edema; Randomized Controlled Trials as Topic; Steroids; Triamcinolone; Visual Acuity; Vitreous Body | 2008 |
17 trial(s) available for triamcinolone and Central Retinal Edema, Cystoid
Article | Year |
---|---|
Real-World Results of Intravitreal Ranibizumab, Bevacizumab, or Triamcinolone for Diabetic Macular Edema.
Topics: Angiogenesis Inhibitors; Bevacizumab; Diabetic Retinopathy; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Glucocorticoids; Humans; Intravitreal Injections; Macular Edema; Male; Middle Aged; Ranibizumab; Receptors, Vascular Endothelial Growth Factor; Retrospective Studies; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone; Visual Acuity | 2018 |
Strategy for the management of macular edema in retinal vein occlusion: the European VitreoRetinal Society macular edema study.
Topics: Antibodies, Monoclonal, Humanized; Bevacizumab; Dexamethasone; Humans; Intravitreal Injections; Macular Edema; Retinal Vein Occlusion; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone; Vascular Endothelial Growth Factor A; Visual Acuity; Vitrectomy | 2015 |
Comparison of combination posterior sub-tenon triamcinolone and modified grid laser treatment with intravitreal triamcinolone treatment in patients with diffuse diabetic macular edema.
Topics: Adult; Aged; Anti-Inflammatory Agents; Diabetic Retinopathy; Female; Fovea Centralis; Humans; Laser Coagulation; Macular Edema; Male; Middle Aged; Prospective Studies; Triamcinolone; Visual Acuity; Vitreous Body | 2008 |
Laser photocoagulation versus combined laser photocoagulation and posterior sub-Tenon's triamcinolone injection for the primary treatment of diffuse diabetic macular edema.
Topics: Aged; Angiography; Anti-Inflammatory Agents; Chronic Disease; Combined Modality Therapy; Diabetes Complications; Female; Humans; Intraocular Pressure; Lasers; Light Coagulation; Macula Lutea; Macular Edema; Male; Middle Aged; Prospective Studies; Treatment Outcome; Triamcinolone; Uveitis | 2010 |
[Comparison of pars plana vitrectomy with ILM peeling and intravitreal triamcinolone in diffuse diabetic macular oedema].
Topics: Aged; Anti-Inflammatory Agents; Diabetic Retinopathy; Female; Humans; Macular Edema; Male; Middle Aged; Triamcinolone; Vitrectomy; Vitreous Body | 2010 |
[Focal laser photocoagulation in patients with diabetic macular edema after pretreatment with triamcinolone: 6-month results].
Topics: Aged; Anti-Inflammatory Agents; Combined Modality Therapy; Diabetic Retinopathy; Female; Humans; Laser Coagulation; Macular Edema; Male; Premedication; Treatment Outcome; Triamcinolone | 2010 |
Intravitreal bevacizumab with or without triamcinolone for refractory diabetic macular oedema.
Topics: Adult; Aged; Angiogenesis Inhibitors; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Diabetic Retinopathy; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Intravitreal Injections; Macular Edema; Male; Middle Aged; Treatment Outcome; Triamcinolone | 2010 |
Intravitreal Bevacizumab with or without triamcinolone for refractory diabetic macular oedema.
Topics: Adult; Aged; Antibodies, Monoclonal, Humanized; Bevacizumab; Diabetic Retinopathy; Drug Therapy, Combination; Female; Humans; Intravitreal Injections; Macular Edema; Male; Middle Aged; Triamcinolone | 2011 |
Intravitreal triamcinolone versus laser photocoagulation as a primary treatment for diabetic macular oedema--a comparative pilot study.
Topics: Adult; Aged; Anti-Inflammatory Agents; Diabetic Retinopathy; Female; Humans; Intravitreal Injections; Laser Coagulation; Macular Edema; Male; Middle Aged; Pilot Projects; Severity of Illness Index; Triamcinolone; Visual Acuity | 2011 |
[Intravitreal treatment of patients with branch retinal vein occlusion depending on the duration of macular edema].
Topics: Aged; Angiogenesis Inhibitors; Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Bevacizumab; Female; Humans; Intravitreal Injections; Macular Edema; Male; Retinal Vein Occlusion; Triamcinolone; Vision Disorders; Visual Acuity | 2013 |
Ocular-hypertensive response and corneal endothelial changes after intravitreal triamcinolone injections in Chinese subjects: a 6-month follow-up study.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Cataract Extraction; China; Endothelium, Corneal; Female; Follow-Up Studies; Humans; Injections; Intraocular Pressure; Intraoperative Period; Macular Degeneration; Macular Edema; Male; Middle Aged; Triamcinolone; Vitreous Body | 2005 |
A prospective controlled trial to evaluate the adjunctive role of posterior subtenon triamcinolone in the treatment of diffuse diabetic macular edema.
Topics: Adult; Aged; Diabetes Mellitus, Type 2; Drug Delivery Systems; Female; Follow-Up Studies; Humans; Macular Edema; Male; Middle Aged; Prospective Studies; Triamcinolone | 2004 |
Intravitreal triamcinolone reinjection for refractory diabetic macular edema.
Topics: Diabetic Retinopathy; Female; Follow-Up Studies; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Edema; Male; Prospective Studies; Retreatment; Time Factors; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone; Visual Acuity; Vitreous Body | 2006 |
The -174G/C interleukin-6 promoter polymorphism influences the development of macular oedema following uncomplicated phacoemulsification surgery.
Topics: Aged; Aged, 80 and over; Female; Genetic Predisposition to Disease; Genotype; Glucocorticoids; Humans; Interleukin-6; Macular Edema; Male; Middle Aged; Phacoemulsification; Polymorphism, Genetic; Postoperative Care; Promoter Regions, Genetic; Risk Factors; Triamcinolone | 2007 |
Efficacy and safety of multiple intravitreal triamcinolone injections for refractory diabetic macular oedema.
Topics: Aged; Cataract Extraction; Diabetic Retinopathy; Drug Administration Schedule; Female; Glucocorticoids; Humans; Injections; Macula Lutea; Macular Edema; Male; Middle Aged; Prospective Studies; Treatment Outcome; Triamcinolone; Visual Acuity; Vitreous Body | 2007 |
[Use of triamcinolone and bevacizumab in 25G phaco-vitrectomy surgery for the treatment of cataract and diabetic macular edema].
Topics: Adult; Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Cataract; Combined Modality Therapy; Diabetic Retinopathy; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Macular Edema; Male; Middle Aged; Phacoemulsification; Prospective Studies; Triamcinolone; Vitrectomy | 2008 |
Safety and efficacy of intravitreal triamcinolone for cystoid macular oedema in uveitis.
Topics: Adult; Cataract; Drug Resistance; Fluorescein Angiography; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Edema; Male; Middle Aged; Ocular Hypertension; Prospective Studies; Safety; Treatment Outcome; Triamcinolone; Uveitis, Intermediate; Visual Acuity; Vitreous Body | 2001 |
70 other study(ies) available for triamcinolone and Central Retinal Edema, Cystoid
Article | Year |
---|---|
Diabetic macular edema: Safe and effective treatment with intravitreal triamcinolone acetonide (Taioftal).
Topics: Adult; Aged; Aged, 80 and over; Diabetic Retinopathy; Female; Humans; Intravitreal Injections; Italy; Macular Edema; Male; Middle Aged; Prospective Studies; Treatment Outcome; Triamcinolone | 2021 |
Topical NSAIDs, intravitreal dexamethasone and peribulbar triamcinolone for pseudophakic macular edema.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Dexamethasone; Drug Implants; Glucocorticoids; Humans; Intravitreal Injections; Macular Edema; Retrospective Studies; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone; Visual Acuity | 2021 |
Real-world treatment intensities and pathways of macular edema following retinal vein occlusion in Korea from Common Data Model in ophthalmology.
Topics: Angiogenesis Inhibitors; Bevacizumab; Dexamethasone; Glucocorticoids; Humans; Intravitreal Injections; Macular Edema; Ophthalmology; Retinal Vein Occlusion; Retrospective Studies; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone; Vascular Endothelial Growth Factor A; Visual Acuity | 2022 |
Comparison of Intravitreal Dexamethasone Implant and Posterior Subtenon Triamcinolone Injection in the Treatment of Diabetic Macular Edema in Vitrectomized Eyes.
Topics: Dexamethasone; Diabetes Mellitus; Diabetic Retinopathy; Drug Implants; Glucocorticoids; Humans; Intravitreal Injections; Macular Edema; Retrospective Studies; Treatment Outcome; Triamcinolone; Visual Acuity | 2022 |
A Comparison of Ocular Complications after 0.7 mg Dexamethasone Implant versus 2 mg of Intravitreal Triamcinolone in Vitrectomized Eyes.
Topics: Dexamethasone; Glucocorticoids; Humans; Macular Edema; Ocular Hypertension; Ocular Hypotension; Retrospective Studies; Triamcinolone | 2023 |
Unique case of macular edema following rituximab treatment for antibody-mediated rejection in kidney transplant recipient.
Topics: Female; Glucocorticoids; Graft Rejection; Humans; Immunologic Factors; Kidney Transplantation; Macular Edema; Middle Aged; Rituximab; Triamcinolone | 2021 |
Cost-effectiveness of dexamethasone and triamcinolone for the treatment of diabetic macular oedema in Finland: A Markov-model.
Topics: Aged; Cost-Benefit Analysis; Dexamethasone; Diabetic Retinopathy; Disease Progression; Finland; Follow-Up Studies; Glucocorticoids; Health Care Costs; Humans; Macular Edema; Markov Chains; Quality-Adjusted Life Years; Time Factors; Treatment Outcome; Triamcinolone; Visual Acuity | 2021 |
Difference in the efficacy of intravitreal dexamethasone implant before and after silicone oil removal: A case report.
Topics: Aged; Device Removal; Dexamethasone; Diabetic Retinopathy; Drug Implants; Humans; Intravitreal Injections; Macular Edema; Male; Retinal Detachment; Silicone Oils; Triamcinolone; Vascular Endothelial Growth Factors; Vitrectomy | 2021 |
Bevacizumab for diabetic macular oedema: one-year treatment outcomes from the Fight Retinal Blindness! Registry.
Topics: Angiogenesis Inhibitors; Bevacizumab; Blindness; Diabetes Mellitus; Diabetic Retinopathy; Humans; Intravitreal Injections; Macular Edema; Ranibizumab; Registries; Retrospective Studies; Treatment Outcome; Triamcinolone; Vascular Endothelial Growth Factor A | 2022 |
Detailed analysis of retinal morphology in patients with diabetic macular edema (DME) randomized to ranibizumab or triamcinolone treatment - reply to the letter to the editor.
Topics: Angiogenesis Inhibitors; Diabetic Retinopathy; Humans; Intravitreal Injections; Macular Edema; Ranibizumab; Retina; Treatment Outcome; Triamcinolone; Vascular Endothelial Growth Factor A | 2018 |
Steroid-induced protracted severe ocular hypertension in a 14-year-old girl.
Topics: Adolescent; Female; Glucocorticoids; Humans; Injections, Intraocular; Intraocular Pressure; Macular Edema; Ocular Hypertension; Triamcinolone; Uveitis | 2018 |
The impact of anti-vascular endothelial growth factor agents on visual impairment/blindness prevention in patients with diabetic macular edema and on associated patient and caregiver burden in Japan.
Topics: Aged; Angiogenesis Inhibitors; Blindness; Caregivers; Cost of Illness; Cost-Benefit Analysis; Diabetes Complications; Efficiency; Female; Humans; Intravitreal Injections; Japan; Macular Edema; Male; Markov Chains; Middle Aged; Models, Econometric; Ranibizumab; Receptors, Vascular Endothelial Growth Factor; Recombinant Fusion Proteins; Triamcinolone; Visual Acuity | 2019 |
Fingolimod-associated macular edema: resolution by sub-tenon injection of triamcinolone with continued fingolimod use.
Topics: Administration, Oral; Female; Fingolimod Hydrochloride; Fluorescein Angiography; Glucocorticoids; Humans; Immunosuppressive Agents; Injections, Intraocular; Macular Edema; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Propylene Glycols; Sphingosine; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone | 2013 |
Peristence of triamcinolone crystals after intra-vitreal injection: benign crystalline hyaloidopathy.
Topics: Anti-Inflammatory Agents; Crystallization; Diabetic Retinopathy; Humans; Intravitreal Injections; Macular Edema; Male; Middle Aged; Triamcinolone | 2013 |
[Behcet disease -- case report].
Topics: Adult; Azathioprine; Behcet Syndrome; Cyclosporine; Drug Therapy, Combination; Erythema Nodosum; Female; Follow-Up Studies; Glucocorticoids; Humans; Immunosuppressive Agents; Intravitreal Injections; Macular Edema; Retinal Detachment; Stomatitis, Aphthous; Treatment Outcome; Triamcinolone | 2012 |
Systematic correlation of morphologic alterations and retinal function in eyes with uveitis-associated cystoid macular oedema during development, resolution and relapse.
Topics: Adult; Anti-Inflammatory Agents; Female; Humans; Intravitreal Injections; Macular Edema; Male; Middle Aged; Prospective Studies; Recurrence; Tomography, Optical Coherence; Triamcinolone; Uveitis; Visual Acuity; Visual Field Tests; Visual Fields | 2013 |
Cost-effectiveness of treatment of diabetic macular edema.
Topics: Administration, Ophthalmic; Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Bevacizumab; Combined Modality Therapy; Cost-Benefit Analysis; Diabetic Retinopathy; Disease Progression; Female; Humans; Laser Therapy; Macular Edema; Male; Markov Chains; Middle Aged; Quality-Adjusted Life Years; Receptors, Vascular Endothelial Growth Factor; Recombinant Fusion Proteins; Treatment Outcome; Triamcinolone; Vascular Endothelial Growth Factor A; Visual Acuity | 2014 |
Successful treatment of fingolimod-associated macular edema with intravitreal triamcinolone with continued fingolimod use.
Topics: Aged; Anti-Inflammatory Agents; Female; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Macular Edema; Middle Aged; Multiple Sclerosis; Triamcinolone | 2015 |
[Retinal vein occlusion in a young patient].
Topics: Adult; Diagnosis, Differential; Female; Glucocorticoids; Humans; Intraocular Pressure; Intravitreal Injections; Macular Edema; Magnetic Resonance Angiography; Prognosis; Retinal Vein Occlusion; Treatment Outcome; Triamcinolone | 2013 |
The effect of combined treatment of bevacizumab and triamcinolone for diabetic macular edema refractory to previous intravitreal mono-injections.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Bevacizumab; Diabetic Retinopathy; Drug Therapy, Combination; Female; Fluorescein Angiography; Follow-Up Studies; Fundus Oculi; Glucocorticoids; Humans; Intravitreal Injections; Macular Edema; Male; Middle Aged; Retina; Retrospective Studies; Time Factors; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone; Visual Acuity | 2015 |
[Treatment of postoperative cystoid macular edema (Irvine-Gass syndrome) with dexamethasone 0.7 mg intravitreal implant].
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Cataract Extraction; Dexamethasone; Diabetic Retinopathy; Drug Evaluation; Drug Implants; Humans; Intravitreal Injections; Macular Edema; Middle Aged; Ocular Hypertension; Postoperative Complications; Ranibizumab; Recurrence; Remission Induction; Retinal Detachment; Retrospective Studies; Treatment Outcome; Triamcinolone; Visual Acuity; Vitrectomy | 2016 |
Combined Intravitreal Ranibizumab and Sub-Tenon Injection of Triamcinolone for the Treatment of Diabetic Macular Edema with Retinal Detachment.
Topics: Adult; Aged; Diabetic Retinopathy; Female; Humans; Injections, Intraocular; Intravitreal Injections; Macular Edema; Male; Middle Aged; Ranibizumab; Retrospective Studies; Triamcinolone | 2016 |
[Intramuscular depot steroids : Possible treatment of postsurgical cystoid macula edema with steroid response?]
Topics: Betamethasone; Delayed-Action Preparations; Humans; Injections, Intramuscular; Lenses, Intraocular; Macular Edema; Male; Middle Aged; Phacoemulsification; Postoperative Complications; Recurrence; Reoperation; Retinal Detachment; Tomography, Optical Coherence; Triamcinolone; Vitrectomy | 2017 |
Combined intravitreal triamcinolone injection and laser photocoagulation in eyes with persistent macular edema after branch retinal vein occlusion.
Topics: Aged; Aged, 80 and over; Female; Fluorescein Angiography; Follow-Up Studies; Fovea Centralis; Glucocorticoids; Humans; Injections; Ischemia; Laser Coagulation; Macular Edema; Male; Middle Aged; Retinal Vein Occlusion; Retinal Vessels; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone; Visual Acuity; Vitreous Body | 2008 |
Two non-infectious forms of endophthalmitis after intravitreal triamcinolone and cataract extraction.
Topics: Anti-Inflammatory Agents; Cataract Extraction; Endophthalmitis; Humans; Intravitreal Injections; Macular Edema; Male; Middle Aged; Triamcinolone; Uveitis; Visual Acuity | 2009 |
[Active drainage combined with air-fluid exchange for silicone oil removal: advantages and long-term follow-up].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Air; Emulsions; Female; Follow-Up Studies; Humans; Infusion Pumps, Implantable; Injections; Macular Edema; Male; Middle Aged; Phacoemulsification; Prospective Studies; Recurrence; Retinal Detachment; Silicone Oils; Suction; Triamcinolone; Vitrectomy; Vitreoretinopathy, Proliferative; Vitreous Body | 2008 |
Intravitreal VEGF levels in uveitis patients and treatment of uveitic macular oedema with intravitreal bevacizumab.
Topics: Adult; Aged; Angiogenesis Inhibitors; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Child; Female; Humans; Intravitreal Injections; Macular Edema; Male; Middle Aged; Retina; Triamcinolone; Uveitis; Vascular Endothelial Growth Factor A; Vitreous Body | 2009 |
The response pattern of intravitreal triamcinolone injection for non-AMD macular edema.
Topics: Adult; Age Factors; Aged; Diabetic Retinopathy; Female; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Edema; Male; Middle Aged; Retinal Vein Occlusion; Retrospective Studies; Treatment Outcome; Triamcinolone | 2009 |
Management of lipid exudates in Coats disease by adjuvant intravitreal triamcinolone: effects and complications.
Topics: Adolescent; Chemotherapy, Adjuvant; Child; Child, Preschool; Exudates and Transudates; Follow-Up Studies; Glucocorticoids; Humans; Infant; Injections, Intraocular; Lipid Metabolism; Macular Edema; Male; Retinal Detachment; Retinal Diseases; Retrospective Studies; Telangiectasis; Treatment Outcome; Triamcinolone; Young Adult | 2010 |
Pharmacotherapeutic efficacy of preservative-free intravitreal triamcinolone acetonide.
Topics: Drug Evaluation, Preclinical; Eye Diseases; Humans; Intraocular Pressure; Macular Edema; Meta-Analysis as Topic; Preservatives, Pharmaceutical; Triamcinolone; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2010 |
Retinal vasculopathy associated with mixed connective tissue disease.
Topics: Adrenal Cortex Hormones; Adult; Female; Humans; Immunosuppressive Agents; Macular Edema; Mixed Connective Tissue Disease; Retinal Vasculitis; Retinal Vein Occlusion; Treatment Outcome; Triamcinolone; Visual Acuity | 2010 |
Comparison of intravitreal bevacizumab versus triamcinolone for the treatment of diffuse diabetic macular edema.
Topics: Aged; Angiogenesis Inhibitors; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Diabetic Retinopathy; Female; Follow-Up Studies; Humans; Injections, Intraventricular; Macular Edema; Male; Middle Aged; Radiography; Retina; Retrospective Studies; Statistics, Nonparametric; Tomography, Optical Coherence; Triamcinolone; Visual Acuity | 2010 |
Intravitreal bevacizumab vs intravitreal triamcinolone combined with macular laser grid for diffuse diabetic macular oedema.
Topics: Aged; Aged, 80 and over; Analysis of Variance; Angiogenesis Inhibitors; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Diabetic Retinopathy; Female; Fovea Centralis; Humans; Intravitreal Injections; Laser Coagulation; Macular Edema; Male; Middle Aged; Retrospective Studies; Tomography, Optical Coherence; Triamcinolone; Visual Acuity | 2010 |
Images in clinical medicine. Intravitreal triamcinolone for diabetic macular edema.
Topics: Crystallization; Diabetic Retinopathy; Glucocorticoids; Humans; Macular Edema; Male; Middle Aged; Retina; Tomography, Optical Coherence; Triamcinolone | 2010 |
[Pars plana vitrectomy as anti-inflammatory therapy for intermediate uveitis in children].
Topics: Adolescent; Anti-Inflammatory Agents; Cataract; Child; Child, Preschool; Combined Modality Therapy; Cryotherapy; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Macular Edema; Male; Pars Planitis; Postoperative Complications; Prednisolone; Recurrence; Retrospective Studies; Triamcinolone; Uveitis, Intermediate; Vitrectomy | 2010 |
Frosted branch angiitis, presumably related to dermatomyositis.
Topics: Administration, Oral; Adult; Anti-Inflammatory Agents; Asian People; Dermatomyositis; Diagnosis, Differential; Electromyography; Female; Fundus Oculi; Glucocorticoids; Humans; Intravitreal Injections; Macular Edema; Panuveitis; Prednisolone; Serologic Tests; Triamcinolone; Vasculitis | 2011 |
Practice patterns of Canadian vitreoretinal specialists in diabetic macular edema treatment.
Topics: Aneurysm; Angiogenesis Inhibitors; Anti-Inflammatory Agents; Canada; Diabetic Retinopathy; Health Surveys; Humans; Light Coagulation; Macular Edema; Ophthalmology; Professional Practice; Thiazolidinediones; Triamcinolone; Vascular Endothelial Growth Factor A; Vitrectomy | 2011 |
[Combined pharmacosurgery as treatment for diabetic macular edema: core pars plana vitrectomy and intravitreal injection of bevacizumab and triamcinolone].
Topics: Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Bevacizumab; Combined Modality Therapy; Diabetic Retinopathy; Female; Fluorescein Angiography; Humans; Intravitreal Injections; Macular Edema; Male; Middle Aged; Retrospective Studies; Tomography, Optical Coherence; Triamcinolone; Visual Acuity; Vitrectomy | 2011 |
[Analysis of prognostic factors by spectral-domain optical coherence tomography in pseudophakic cystoid macular oedema].
Topics: Acetazolamide; Aged; Anti-Inflammatory Agents; Diclofenac; Female; Humans; Macular Edema; Male; Postoperative Complications; Prognosis; Pseudophakia; Retrospective Studies; Risk Factors; Tomography, Optical Coherence; Triamcinolone | 2012 |
Combined high-dose sub-tenon triamcinolone, intravitreal bevacizumab, and laser photocoagulation for refractory diabetic macular edema: a pilot study.
Topics: Aged; Angiogenesis Inhibitors; Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Bevacizumab; Diabetic Retinopathy; Drug Therapy, Combination; Female; Humans; Intraocular Pressure; Intravitreal Injections; Laser Coagulation; Macular Edema; Male; Middle Aged; Pilot Projects; Triamcinolone; Visual Acuity | 2012 |
A comparative study between intravitreal triamcinolone and bevacizumab for macular edema due to central retinal vein occlusion with poor vision.
Topics: Antibodies, Monoclonal; Female; Glucocorticoids; Humans; Macular Edema; Male; Retinal Vein Occlusion; Triamcinolone; Vision Disorders | 2012 |
Comparison of natural course, intravitreal triamcinolone, and intravitreal bevacizumab for treatment of macular edema secondary to branch retinal vein occlusion.
Topics: Adult; Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Female; Follow-Up Studies; Glucocorticoids; Humans; Intravitreal Injections; Macula Lutea; Macular Edema; Male; Middle Aged; Retinal Vein Occlusion; Retrospective Studies; Treatment Outcome; Triamcinolone; Visual Acuity | 2013 |
Comparison of natural course, intravitreal triamcinolone and macular laser photocoagulation for treatment of mild diabetic macular edema.
Topics: Aged; Diabetic Retinopathy; Female; Glucocorticoids; Humans; Intravitreal Injections; Light Coagulation; Low-Level Light Therapy; Macular Edema; Male; Middle Aged; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone | 2013 |
Severe sub conjunctival haemorrhage following intravitreal triamcinolone for refractory diabetic oedema.
Topics: Aged; Conjunctival Diseases; Diabetic Retinopathy; Eye Hemorrhage; Glucocorticoids; Humans; Injections; Macular Edema; Male; Triamcinolone; Vitreous Body | 2005 |
It's time for a clinical trial to investigate intravitreal triamcinolone for macular edema due to retinal vein occlusion: the SCORE study.
Topics: Clinical Trials as Topic; Glucocorticoids; Humans; Macular Edema; Retinal Vein Occlusion; Triamcinolone; Vitreous Body | 2005 |
Pattern electroretinogram for monitoring the efficacy of intravitreal triamcinolone injection in diabetic macular edema.
Topics: Diabetes Mellitus, Type 2; Diabetic Retinopathy; Electrooculography; Female; Fluorescein Angiography; Follow-Up Studies; Fundus Oculi; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macula Lutea; Macular Edema; Male; Middle Aged; Triamcinolone; Visual Acuity; Vitreous Body | 2004 |
[Branch retinal vein occlusion treated by intravitreal triamcinolone].
Topics: Aged; Anti-Inflammatory Agents; Female; Glucocorticoids; Humans; Injections; Macular Edema; Male; Middle Aged; Recurrence; Retinal Vein Occlusion; Time Factors; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone; Visual Acuity; Vitreous Body | 2005 |
Conjunctival necrosis following intravitreal injection of triamcinolone acetonide.
Topics: Conjunctiva; Conjunctival Diseases; Follow-Up Studies; Glucocorticoids; Humans; Injections; Macular Edema; Male; Middle Aged; Necrosis; Triamcinolone; Vitrectomy; Vitreous Body | 2005 |
[Surgical therapy of diabetic retinopathy].
Topics: Blindness; Blood Glucose; Diabetic Retinopathy; Fluorescein Angiography; Humans; Laser Coagulation; Macular Edema; Retina; Retinal Detachment; Tomography, Optical Coherence; Triamcinolone; Vitreoretinopathy, Proliferative | 2005 |
Intravitreal triamcinolone for the treatment of macular oedema.
Topics: Chronic Disease; Glucocorticoids; Humans; Injections; Macular Edema; Time Factors; Triamcinolone; Visual Acuity; Vitreous Body | 2006 |
[Pseudophakic cystoid macular edema. Assessment with optical coherence tomography].
Topics: Aged; Cataract Extraction; Female; Fluorescein Angiography; Fundus Oculi; Glucocorticoids; Humans; Incidence; Macular Edema; Male; Prospective Studies; Pseudophakia; Tomography, Optical Coherence; Triamcinolone | 2006 |
[Pars plana vitrectomy and intravitreal triamcinolone for chronic pseudophakic cystoid macular edema].
Topics: Aged; Cataract Extraction; Chronic Disease; Combined Modality Therapy; Female; Glucocorticoids; Humans; Intraocular Pressure; Macular Edema; Male; Middle Aged; Pseudophakia; Triamcinolone; Visual Acuity; Vitrectomy; Vitreous Body | 2006 |
Early effects of intravitreal triamcinolone on macular edema: mechanistic implication.
Topics: Aged; Aged, 80 and over; Diabetic Retinopathy; Female; Glucocorticoids; Humans; Injections; Macula Lutea; Macular Edema; Male; Middle Aged; Retinal Vein Occlusion; Time Factors; Tomography, Optical Coherence; Triamcinolone; Vitreous Body | 2006 |
Globe rupture as a complication of intravitreal injection of triamcinolone.
Topics: Aged, 80 and over; Glucocorticoids; Humans; Injections; Macular Edema; Male; Rupture; Sclera; Triamcinolone; Vitreous Body | 2007 |
The inadvertent administration of intralenticular triamcinolone.
Topics: Aged, 80 and over; Glucocorticoids; Humans; Injections; Lens, Crystalline; Macular Edema; Male; Medication Errors; Triamcinolone; Vitreous Body | 2007 |
[Uveitic cystoid macular edema: intravitreal triamcinolone].
Topics: Adult; Aged; Anti-Inflammatory Agents; Female; Humans; Macular Edema; Male; Middle Aged; Treatment Outcome; Triamcinolone; Uveitis; Vision Disorders; Visual Acuity; Vitreous Body | 2007 |
A case of cystoid macular edema treated by intravitreal triamcinolone in a patient with systemic lupus erythematosis.
Topics: Female; Glucocorticoids; Humans; Injections; Lupus Erythematosus, Systemic; Macular Edema; Middle Aged; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone; Visual Acuity; Vitreous Body | 2006 |
Optical coherence tomographic pattern may predict visual outcome after intravitreal triamcinolone for diabetic macular edema.
Topics: Aged; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Female; Glucocorticoids; Humans; Injections; Macular Edema; Male; Prospective Studies; Retina; Retrospective Studies; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone; Visual Acuity; Vitreous Body | 2007 |
The effect of intravitreal triamcinolone on intraocular pressure.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Diabetic Retinopathy; Drug Administration Routes; Drug Administration Schedule; Glaucoma, Open-Angle; Humans; Injections; Intraocular Pressure; Macular Degeneration; Macular Edema; Middle Aged; Retrospective Studies; Risk Factors; Triamcinolone | 2007 |
Intravitreal triamcinolone and bevacizumab combination therapy for macular edema due to central retinal vein occlusion refractory to either treatment alone.
Topics: Aged; Angiogenesis Inhibitors; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Drug Therapy, Combination; Humans; Macular Edema; Male; Retinal Vein Occlusion; Treatment Outcome; Triamcinolone | 2007 |
Intravitreal triamcinolone for cystoid macular edema related to branch retinal vein occlusion.
Topics: Aged; Aged, 80 and over; Female; Humans; Macular Edema; Male; Middle Aged; Retinal Vein Occlusion; Retrospective Studies; Triamcinolone; Vitreous Body | 2006 |
Evaluation of the efficacy of vitrectomy for persistent diabetic macular edema and associated factors predicting outcome.
Topics: Adult; Aged; Diabetic Retinopathy; Female; Humans; Injections; Laser Coagulation; Macular Edema; Male; Middle Aged; Retreatment; Retrospective Studies; Treatment Outcome; Triamcinolone; Vitrectomy; Vitreous Body | 2007 |
Optical coherence tomography.
Topics: Diabetes Mellitus, Type 2; Diabetic Retinopathy; Glucocorticoids; Humans; Injections; Macular Edema; Retina; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone; Visual Acuity; Vitreous Body | 2008 |
Intravitreal triamcinolone injection for unresponsive cystoid macular oedema in probable Behçet's disease as an additional therapy.
Topics: Adult; Anti-Inflammatory Agents; Behcet Syndrome; Chemotherapy, Adjuvant; Humans; Injections; Macular Edema; Male; Treatment Outcome; Triamcinolone; Vitreous Body | 2008 |
Posterior sub-Tenon injections of repository corticosteroids in uveitis patients with cystoid macular edema.
Topics: Adolescent; Adult; Aged; Fascia; Female; Fluorescein Angiography; Fundus Oculi; Humans; Injections; Macular Edema; Male; Methylprednisolone; Middle Aged; Orbit; Prognosis; Suspensions; Triamcinolone; Uveitis; Visual Acuity | 1995 |
Macular edema in chronic Vogt-Koyanagi-Harada syndrome.
Topics: Adolescent; Anti-Inflammatory Agents; Chronic Disease; Fascia; Female; Fluorescein Angiography; Fundus Oculi; Humans; Injections; Macular Edema; Male; Middle Aged; Retrospective Studies; Triamcinolone; Uveomeningoencephalitic Syndrome; Visual Acuity | 1995 |
Cystoid macular edema following combined phacoemulsification and vitrectomy for macular hole.
Topics: Aged; Cataract; Conjunctiva; Female; Fluorescein Angiography; Follow-Up Studies; Fundus Oculi; Glucocorticoids; Humans; Injections; Macular Edema; Male; Middle Aged; Phacoemulsification; Retinal Perforations; Retrospective Studies; Triamcinolone; Visual Acuity; Vitrectomy | 1998 |
Effective local treatment for severe ocular inflammatory disease: toward the Holy Grail.
Topics: Glucocorticoids; Humans; Macular Edema; Triamcinolone; Uveitis; Vitreous Body | 2001 |
Retinal and choroidal vascular occlusion after posterior sub-tenon triamcinolone injection.
Topics: Adult; Antihypertensive Agents; Choroid; Choroid Diseases; Fascia; Female; Fluorescein Angiography; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Edema; Massage; Ocular Hypertension; Pain; Retinal Artery Occlusion; Retinal Hemorrhage; Retrospective Studies; Triamcinolone; Uveitis; Visual Acuity | 2002 |
Posterior sub-Tenon's injections of corticosteroids in uveitis patients with cystoid macular edema.
Topics: Adolescent; Adult; Blood-Retinal Barrier; Eye; Female; Fluorescein Angiography; Humans; Injections, Intramuscular; Macular Edema; Male; Methylprednisolone; Middle Aged; Permeability; Retina; Time Factors; Triamcinolone; Uveitis; Visual Acuity | 1988 |